Northwestern Mutual Wealth Management
SNDX icon

Northwestern Mutual Wealth Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62K Hold
74
– – ﹤0.01% 3700
2026
Q1 		$1.73K Buy
+74
New +$1.61K ﹤0.01% 3639
2024
Q3 		– Sell
-1,300
Closed -$26.7K – 3825
2024
Q2 		$26.7K Buy
+1,300
New +$27.2K ﹤0.01% 2307
2024
Q1 		– Sell
-50
Closed -$1.08K – 3789
2023
Q4 		$1.08K Buy
+50
New +$769 ﹤0.01% 3162

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Northwestern Mutual Wealth Management's SNDX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 74 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3700.

Northwestern Mutual Wealth Management first reported a position in SNDX in Q4 2023 and has held it in 4 quarters since. The position peaked at $26.7K in Q2 2024. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 74 shares of Syndax Pharmaceuticals worth $1.62K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3700 holding.
  • Northwestern Mutual Wealth Management first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • Northwestern Mutual Wealth Management's Syndax Pharmaceuticals position peaked at $26.7K in Q2 2024.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.